How do you pay?

How to pay the least

Ask for the cash price

Filspari

We didn’t find one.

  1. Ask your pharmacy for Filspari’s cash price, and one or two other pharmacies too.
  2. Filspari’s savings card works only with insurance from a job or one you bought.

Compare every option

Question
Brand nameFilspari
Authorized genericsparsentan
Regular genericsparsentan
What you’d pay
Cash priceAsk the pharmacy
Not soldThere isn’t one
Not soldNone found
Same as Filspari?
The original
–
–

Brand nameThe maker’s card

Travere TotalCare copay support program

Savings card from Travere Therapeutics

No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as $0 a month

Sign up on filspari.com 

Or call 1-833-345-7727.

In the maker’s words

“Eligible, commercially insured patients may pay as little as $0 per month through the Travere copay support program.”

From the maker’s offer on filspari.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Filspari itself, from the same company, sold without the brand name, and usually for less. For now Filspari is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

We didn’t find one. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

FILSPARI is an endothelin and angiotensin II receptor antagonist indicated:

  • To slow kidney function decline in adults with primary immunoglobulin A nephropathy (IgAN) who are at risk for disease progression.
  • To reduce proteinuria in adult and pediatric patients aged 8 years and older with focal segmental glomerulosclerosis (FSGS) without nephrotic syndrome.

Source: the FDA label for Filspari (Travere Therapeutics, Inc.), April 9, 2026. Full label on DailyMed 

Good to know